Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

AXA Framlington UK Select Opportunities R Inc

Ranked 196 out of 250 in - UK (All Companies) over 12 months
All calculations are in GBP unless stated

Managed by

Nigel Thomas

Nigel Thomas is one of the few fund managers who can boast a career record of more than 15 years at the helm of UK-oriented unit trusts and he has built an impressive record over this period. Thomas learned his trade at the hands of legendary stockmarket investor John Carrington before Carrington's company was sold to Dutch bank ABN Amro. Early in 2002 Framlington (now AXA Framlington) lured him across to the other side of Bishopsgate in the heart of the City. Thomas, an Economics and Geography graduate from UCL and a keen horseracing fan, has worked alongside George Luckraft for this entire period and they are seen as inseparable. Thomas made particularly impressive returns for his investors during the stockmarket rally of late 1999/early 2000 but unlike many of his rivals he managed to retain much of these gains in the ensuing bear market. A growth-oriented investor, he tends to run his funds with approximately one-third of his assets exposed to each of the large-cap, mid-cap and small-cap areas of the stockmarket. He is responsible for AXA Framlington UK Select Opportunities fund.


The Fund will ordinarily invest at least 80% of its assets in companies, primarily of UK origin, where the Manager believes above returns can be realised.

Showing fund performance in United Kingdom View performance globally


UK (All Companies) over : 30/09/2015 - 30/09/2016

Total Return

Quarterly Performance

to 30/09/2016 Annual Q1 Q2 Q3 Q4
2016 -3.9% -5.9% 10.2%
2015 8.4% 5.6% 0.7% -5.3% 7.6%
2014 0.1% 0.9% -2.2% -0.1% 1.5%
2013 28.9% 12.4% -0.3% 7.1% 7.5%
2012 10.7% 8.8% -4.9% 6.1% 0.9%
2011 -0.2% 0.3% 3.2% -11.9% 9.5%
2010 27.0% 5.2% -5.5% 16.2% 9.9%
2009 34.2% -8.0% 14.8% 19.9% 5.9%
2008 -29.3% -8.2% 1.7% -15.4% -10.5%
2007 3.8% 4.2% 1.9% -3.2% 1.0%
2006 18.2% 10.1% -3.0% 3.9% 6.5%
2005 24.6% 4.0% 3.8% 10.3% 4.7%
2004 23.6% 10.0% 3.3% 1.8% 6.9%
2003 36.5% -7.0% 21.4% 13.8% 6.3%
2002 -0.2%

Month by Month Performance

Returns Vs Risk

Asset Allocation



Top 10 Holdings

Stock Size
RPC Group PLC ORD 5.51
Paddy Power Betfair PLC ORD 5.00
Rightmove PLC ORD 4.69
GlaxoSmithKline PLC ORD 4.24
BT Group PLC ORD 3.61
AstraZeneca PLC ORD 3.48
Vodafone Group PLC ORD 3.33
Dixons Carphone PLC ORD 3.06

Registered For Sale In

  1. Switzerland
  2. United Kingdom

Fund Info

  • Launch date31/01/1969
  • Share Class size3,863Mn
  • Base currencyGBP
  • ISIN GB0003501698

Purchase Info

  • Min. initial investment1,000
  • Min. regular additional investment50


  • Annual management1.50%
  • Initial investment5.25

Related News

FTSE races towards record high as pound drops

FTSE 100 eyes all-time high, boosted by fall in pound, still heavily down on the day despite recovery from overnight 'flash crash'.

Builders weigh on FTSE as house price fall tipped

House builders drag down FTSE 100 as RICS survey points to first fall in UK property prices since 2012.

AXA Framlington UK Select Opportunities

Nigel Thomas buys Shell and redeploys Shire windfall

Nigel Thomas, manager of the AXA Framlington UK Select Opportunities fund adds Royal Dutch Shell to its holdings and has re-invested capital from Shire Pharmaceutical.

SGPB Hambros' Verleyen ups alternatives allocation on volatility fears

SocGen’s Eric Verleyen is running with 21% exposure to alternatives in the firm’s Balanced mandate due to concerns about volatility remaining at elevated levels.

FTSE rebounds as US jobs data cheer markets

(Update) The US created more jobs than expected last month.

AXA IM introduces single pricing across fund range

The fund will no longer employ dual pricing in a bid to simplify the buying and selling process for investors.

Shire up, Xaar down; FTSE falls as inflation drops

The FTSE 100 falls back after a drop in UK inflation increases interest rate uncertainty. Shire rises on bid talk, Xaar dives on a profits alert.

Nigel Thomas: why I bought AstraZeneca before the bid

Citywire AA-rated Nigel Thomas bought into Astra-Zeneca ahead of its takeover offer from Pfizer

AXA IM £10.2bn inflow powered by Framlington & bonds

The continued popularity of the likes of AXA Framlington's UK equity manager Nigel Thomas helped fuel a significant increase in inflows at the firm in 2013.


Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).